Review Article
Volume 19 Issue 8 - 2020
An Introduction to Botulinum Toxin and Dermal Fillers for Dentists: Part 1
Mohamad Hani Nouri Dalati1* and Lara Taher Koussayer2
1Consultant Orthodontist and Medical Director, Tajmeel Specialized Medical Center, Abu Dhabi, UAE
2Cosmetic Gynaecologist/Specialist, Danat Al Emirates Hospital, Abu Dhabi, UAE
*Corresponding Author: Mohamad Hani Nouri Dalati, Consultant Orthodontist and Medical Director, Tajmeel Specialized Medical Center, Abu Dhabi, UAE.
Received: July 15, 2020; Published: July 28, 2020


Non-surgical facial rejuvenation using chemicals like botulinum toxin and hyaluronic acid is gaining an increasing popularity in the middle east and in different parts of the world over the last 10 years. These three papers aim at filling the gap in the dental literature with regards to this new and fast developing field of treatment and at giving an overview on such chemicals used currently in enhancing facial aesthetics and their potential use in dental practices.

Clinical Relevance: Facial rejuvenation substances have an important role to play in enhancing the appearance of our dental patients, particularly in “Gummy Smile” cases and cases with masseter hypertrophy or mild facial asymmetry/disharmony. Their medical uses are well established but some of their aesthetic benefits and dentally-related uses have just been approved in the recent years. This article will generally introduce botulinum toxin and hyaluronic acid to our dental fellow colleagues and provide them with the basic knowledge that will support them throughout their facial rejuvenation journey.

Keywords: Botulinum Toxin; Hyaluronic Acid; Facial Rejuvenation; Dermal Fillers


  1. Alam M., et al. “Botulinum Toxin A Injection in the Bladder Neck: A Promising Treatment for Urinary Retention”. Case Reports in Urology (2016): 3. 
  2. Brashear A. “Botulinum toxin type A: Exploring new indications”. Drugs Today 46.9 (2010): 671-682.
  3. Carruthers A and Carruthers J. “History of the cosmetic use of Botulinum A exotoxin”. Dermatologic Surgery 24.11 (1998): 1168-1170.
  4. Schantz EJ and Johnson EA. “Botulinum toxin: the story of its development for the treatment of human disease”. Perspectives in Biology and Medicine 40.3 (1997): 317-327. 
  5. Wortzman MS and Pickett A. “The science and manufacturing behind botulinum neurotoxin type A-ABO in clinical use”. Aesthetic Surgery Journal 29.6 (2009): S34-S42.
  6. Thakker MM and Rubin AD. “Pharmacology and clinical applications of botulinum toxins A and B”. International Ophthalmology Clinics 44.3 (2004): 147-163.
  7. Simpson LL. “Identification of the major steps in botulinum toxin action”. Annual Review of Pharmacology and Toxicology 44 (2004): 167-193.
  8. Simpson LL. “The structure and mechanism of action of botulinum toxin”. Movement Disorders 10.3 (1995): 362.
  9. Grunfeld A., et al. “Botulinum toxin for hyperhidrosis: a review”. American Journal of Clinical Dermatology 10.2 (2009): 87-102.
  10. Wieder JM and Moy RL. “Understanding botulinum toxin. Surgical anatomy of the frown, forehead, and periocular region”. Dermatologic Surgery 24.11 (1998): 1172-1174. 
  11. Dutton JJ. “Atlas of Clinical and Surgical Orbital Anatomy”. Philadelphia: WB Saunders (1994). 
  12. Cook BE Jr., et al. “Depressor supercilii muscle: anatomy, histology, and cosmetic implications”. Ophthalmic Plastic and Reconstructive Surgery 17.6 (2001): 404-411. 
  13. Pribitkin EA., et al. “Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection”. Archives of Otorhinolaryngology-Head and Neck Surgery 123.3 (1997): 321-326.
  14. Bakheit AM. “The possible adverse effects of intramuscular botulinum toxin injections and their management”. Current Drug Safety 1.3 (2006): 271-279.
  15. Felber ES. “Botulinum toxin in primary care medicine”. The Journal of the American Osteopathic Association 106.10 (2006): 609-614.
  16. Wollina U and Konrad H. “Managing adverse events associated with botulinum toxin type A: a focus on cosmetic procedures”. American Journal of Clinical Dermatology 6.3 (2005): 141-150.
  17. Gracco A and Tracey S. “Botox and the gummy smile”. Progress in Orthodontics 11.1 (2010): 76-82.
  18. Polo M. “Botulinum toxin type A (Botox) for the neuromuscular correction of excessive gingival display on smiling (gummy smile)”. American Journal of Orthodontics and Dentofacial Orthopedics 133.2 (2008): 195-203.
  19. Kim NH., et al. “Botulinum toxin type A for the treatment of hypertrophy of the masseter muscle”. Plastic and Reconstructive Surgery 125.6 (2010): 1693-705.
  20. Mauskop A. “Botulinum neurotoxin in the treatment of headache disorders”. The Handbook of Clinical Neurology 97 (2010): 217-232.
  21. Song PC., et al. “The emerging role of botulinum toxin in the treatment of temporomandibular disorders”. Oral Diseases 13.3 (2007): 253-260.
Citation: Mohamad Hani Nouri Dalati and Lara Taher Koussayer. “An Introduction to Botulinum Toxin and Dermal Fillers for Dentists: Part 1”. EC Dental Science 19.8 (2020): 142-157.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

February Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the February issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before February 17, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.